Showing results (2141-2150 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|December 27, 2011
In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03Meehyein Kim, Joung Han Yim, So-Yeon Kim, et al.Antiviral Research|December 27, 2011
In vitro resistance selections using elvitegravir, raltegravir, and two metabolites of elvitegravir M1 and M4Nicolas A Margot, Rebecca M Hluhanich, Gregg S Jones, et al.Antiviral Research|March 6, 2012
The 1α,25-dihydroxy-vitamin D3 reduces dengue virus infection in human myelomonocyte (U937) and hepatic (Huh-7) cell lines and cytokine production in the infected monocytesHenry Puerta-Guardo, Fernando Medina, Sergio Isaac De la Cruz Hernández, et al.Antiviral Research|December 14, 2011
Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivoTakehiro Himaki, Yumi Masui, Koji Chono, et al.Antiviral Research|January 6, 2015
Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitroA C G Jardim, Z Igloi, J F Shimizu, et al.Antiviral Research|June 1, 1989
Oral chemotherapy of fatal B virus (herpesvirus simiae) infectionH T Zwartouw, C R Humphreys, P CollinsAntiviral Research|December 3, 2014
Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragmentsO V Matusevich, V V Egorov, I A Gluzdikov, et al.Antiviral Research|December 3, 2014
Nanotech-derived topical microbicides for HIV prevention: the road to clinical developmentJavier Sánchez-Rodríguez, Enrique Vacas-Córdoba, Rafael Gómez, et al.Antiviral Research|December 3, 2014
Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycleThomas J Gardner, Tobias Cohen, Veronika Redmann, et al.Antiviral Research|December 3, 2014
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this modelAnn E Tollefson, Jacqueline F Spencer, Baoling Ying, et al.Pageof 523